Australian Doctor 16th June 2023 16JUNE2023 issue | Page 4

4 NEWS
For more information , contact your local representative or visit www . oncobeta . com

4 NEWS

16 JUNE 2023 ausdoc . com . au

GPs criticised for ignoring red alerts

The doctors received script warnings yet failed to check the prescribing history of a patient who later died of an overdose , an investigation found .
Heather Saxena

A

PATIENT who overdosed on tapentadol and oxycodone triggered 77 red flags in the real-time prescription monitoring system SafeScript , but doctors only checked his prescribing history on six occasions , a coroner has found .
Victorian Coroner Audrey Jamieson has criticised almost a dozen doctors for their prescribing , as well as the state Department of Health , saying it should have warned prescribers that they were breaking the law by not checking Safe- Script when required .
She was investigating the death of 46-year-old Bradley Liefvoort , who received a total of 988 tapentadol tablets and 1785 oxycodone tablets over six months .
He was found dead in June 2021 still “ clutching ” his medication , with boxes of
S4 and S8 drugs sourced from 14 different pharmacies scattered around his apartment and in his car .
“ At the time of Bradley ’ s death , Safe- Script had already been compulsory to use for more than a year when prescribing or dispensing either of the two drugs that contributed centrally to the death : oxycodone and tapentadol ,” Ms Jamieson said .
“ I thought it very reasonable to expect that the clinicians involved in Bradley ’ s care — particularly in the months leading up to his death — should have been very familiar with the functioning of the SafeScript platform and its stated objectives .”
Two of the doctors were now under AHPRA investigation , she said .
But the fact that Mr Liefvoort received scripts from so many doctors suggested “ the SafeScript system either was not working as intended or was not
being used as required by his prescribing clinicians ”.
While Mr Liefvoort ’ s drug dependence had started a decade earlier , the investigation focused on the six months leading up to his death when there was an “ escalation ” in his drug-seeking behaviour following the breakdown of his marriage .
Investigators found that 14 doctors had prescribed the drugs to Mr Liefvoort over this period , including 10 GPs across three practices , one hospital intern and one after-hours doctor .
But his SafeScript record had only been accessed six times — around one in every 13 prescriptions .
At least three GPs had received red alerts indicating that their patient had been prescribed the same drug by four or more doctors , or prescribed high-risk combinations of drugs , yet they failed to check the system .
One said they were unable to access the SafeScript system until the next day because of a technical issue .
Another GP said that they did not “ recall any SafeScript warning at the

Save face with Rhenium-SCT ® 1 , 2

Painless 2 , 3 ‡

No reported pain .

Single-Session 2-4 §

§
Complete tumour regression in 98.5 % of lesions treated .

Precise 1 , 2 †

Accurate dosing . Spares underlying layers of healthy tissue .
The non-invasive * procedure targets non-melanoma skin cancers . 3 It is applied by a paste directly to the lesion , and leaves no disfiguring scarring . 1 , 3
*
A procedure is considered non-invasive when no break or cut in the skin is created . 5
For more information , contact your local representative or visit www . oncobeta . com
References : 1 . Cipriani C , et al . International J Nucl Med . 2017 ; July : 114 – 112 . 2 . Cipriani C , et al . J Dermatol Treat . 2020 ; DOI : 10.1080 / 09546634.2020.1793890 . 3 . Castellucci P , et al . Eur J Nucl Med Mol Imaging . 2021 ; 48 ( 5 ): 1511 – 1521 . 4 . Cipriani C , et al . In Therapeutic Nuclear Medicine . 2014 . RP Baum ( Ed ), New York : Springer . 5 . Australian Therapeutic Goods Administration . ARTG Public summary 400142 .
Please review the Product and User information before use . This can be accessed at www . oncobeta . com . Indication : Rhenium-188 paste for the treatment of skin cancer lesions and skin tumours . Currently not MBS funded . OncoBeta ® GmbH , Schleißheimer Str . 91 , 85748 Garching near Munich , GERMANY . SHOW4045 . B . Date of preparation : May 2023